Value in Pharmaceutical Pricing [E-Book] / Valérie Paris and Annalisa Belloni
Paris, Valérie.
Belloni, Annalisa.
Paris : OECD Publishing, 2013
74 p. ; 21 x 29.7cm.
englisch
10.1787/5k43jc9v6knx-en
OECD Health Working Papers ; 63
Social Issues/Migration/Health
Full Text
This study analyses how 14 OECD Countries refer to "value" when making decisions on reimbursement and prices of new medicines. It details the type of outcomes considered, the perspective and methods adopted for economic evaluation when used; and the consideration of budget impact. It describes which dimensions are taken into account in the assessment of "innovativeness" and the consequences of this assessment on prices; it confirms that treatments for severe and/or rare diseases are often more valued than others and shows how countries use product-specific agreements in an attempt to better align value and price.